Hawaii 2022 Regular Session

Hawaii Senate Bill SB3136

Introduced
1/26/22  
Refer
1/26/22  
Report Pass
2/18/22  
Refer
2/18/22  
Report Pass
3/4/22  
Engrossed
3/8/22  

Caption

Relating To The Electronic Prescription Accountability System.

Impact

The bill's enactment will result in stricter reporting regulations for healthcare providers and dispensers involved in the distribution of controlled substances. It seeks to ensure a more effective tracking system for prescriptions, thus enhancing monitoring of prescription patterns and reducing the risk of misuse. By having this data reported in real-time, state health agencies can better manage public health risks associated with controlled substances, while also increasing transparency in prescription drug use.

Summary

Senate Bill 3136 aims to enhance the management of prescriptions for controlled substances in Hawaii by amending existing regulations. Specifically, the bill requires that dispensers of controlled substances report the filling of prescriptions in real-time to the state's Electronic Prescription Accountability System. If no prescriptions are filled, dispensers must report 'zero' at least once every seven days. This legislative change is intended to improve oversight and accountability in the prescription process, potentially aiding in the fight against prescription drug abuse and mismanagement.

Sentiment

General sentiment around SB 3136 appears to be supportive, particularly among legislators concerned with public health and combating opioid abuse. The requirement for real-time reporting is regarded as a progressive step for ensuring accountability within the healthcare system. However, there may be concerns among pharmacy practitioners regarding the feasibility and administrative burden of real-time data entry, which could trigger discussions regarding the resources required to implement these changes effectively.

Contention

Notable points of contention include the potential implications of increased burdens on healthcare professionals required to comply with the new reporting mandates. While the objective is to enhance accountability, some stakeholders may argue that the operational impact on dispensers could be significant. Additionally, the timeframe for reporting could be critiqued as cumbersome, as it demands a high-frequency data update that may not have been previously standard practice.

Companion Bills

HI HB2168

Same As Relating To The Electronic Prescription Accountability System.

Similar Bills

CA AB149

Controlled substances: prescriptions.

AZ HB2291

Opioids; containers; labeling; requirements; repeal

AZ SB1254

Opioids; containers; labeling; requirements; repeal

CA AB1998

Opioids: safe prescribing policy.

TX HB2766

Relating to electronic and other controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.

TX HB2174

Relating to controlled substance prescriptions and reimbursement for treatment for certain substance use disorders; authorizing a fee.

TX SB1233

Relating to controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.

CA AB845

Cannabidiol.